Catalyze Dallas announced it has expanded the role of Chief Financial Officer James Bendle to include serving as a partner for the company.

Bendle was named CFO in 2021, and the company said he has deftly guided Catalyze by growing the portfolio companies that existed at that time, Alpine Advanced Materials and Metro Aerospace, and by playing a pivotal role in the successful launch of its most recent 2022 spinout, Almaden Genomics.

Joe D’Cruz, co-founder and managing director of the company, said, “It’s hard to imagine a time before James was part of our team.”

D’Cruz says Bendle’s acumen in financial matters and leadership “make him a truly gifted executive.” The company recognizes his influence inside the Catalyze organization and its “dozen-plus” Fortune 100 clients and investment partners.

D’Cruz says the company is making it official: “We’ve been lucky to work with him closely as a partner, and are pleased to now formally give him that title.”

Bendle came to Catalyze as its first CFO as the company said it was preparing to expand its portfolio.

Before Catalyze, Bendle was senior vice president of finance for CesiumAstro, a space communications equipment company. Before that, he was vice president of finance for the investment division of Silicon Valley-based Flex, where he negotiated investment and spinout agreements as the company monetized vast technology capabilities.

The company said that over his nearly three-decade career, he has built finance and investment organizations at companies ranging from startup to Fortune 50.

Catalyze said it assesses hundreds of technology assets and business units each year and accelerates commercialization of the most promising intellectual property from the Fortune 100 to unleash the full value and potential of R&D investments in technology.

Get on the list.
Dallas Innovates, every day.

Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.